Walleye Trading’s Century Therapeutics IPSC Stock Holding History

Walleye Trading’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,385	Closed	-$122K	–	5171
2022 Q3	$122K	Buy	+12,385	New	+$130K	﹤0.01%	3976

Other funds holding IPSC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Walleye Trading's IPSC Position: Q4 2022 in Review

Walleye Trading sold out of Century Therapeutics (IPSC) in Q4 2022, closing a stake of 12,385 shares — an estimated $122K sold.

Walleye Trading first reported a position in IPSC in Q3 2022 and held it in 1 quarter. The position peaked at $122K in Q3 2022. 65 funds tracked by Wall St. Rank hold IPSC as of Q4 2022.

Walleye Trading reported no remaining Century Therapeutics position as of Q4 2022 after selling out during the quarter.
Walleye Trading sold 12,385 Century Therapeutics shares in Q4 2022, an estimated $122K.
Walleye Trading first reported a position in Century Therapeutics in Q3 2022 and held it in 1 quarter.
Walleye Trading's Century Therapeutics position peaked at $122K in Q3 2022.
65 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.